Smart Inhalers Companies
Smart inhalers are innovative devices that help individuals manage respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD) by providing accurate dosing information and tracking medication usage.
Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Disclaimer: List of key companies in no particular orderLatest Smart inhalers Companies Update
-
July 2023: Teva introduced a digitally-enabled inhaler for patients with asthma and chronic obstructive pulmonary disease (COPD) in the UK, the device's first European market. In-built sensors on the GoResp Digihaler, which administers the long-acting beta agonist formoterol and the inhaled corticosteroid budesonide, identify and log information on a patient's usage of and proficiency with the inhaler. Through a Bluetooth connection, users may examine the findings on a companion app and share the information with their healthcare physician. Teva claims that this is the first integrated inhaler device equipped with sensors that can identify and document objective information about the patient using the device, such as inspiratory flow measurements that can help categorize respiratory symptoms. To increase patient compliance, the companion app also has a feature that allows patients to be reminded when to take their prescription.
-
June 2023: With the collaboration with Teva Pharmaceuticals, Phil Inc., a patient access platform firm that is revolutionizing life science product commercialization, will enable Digihaler® medicines to be prescribed through the PhilRx Patient Access Platform. The first and only smart inhaler device capable of offering objective inhaler data to enable educated treatment discussions between patients and physicians on asthma management is Teva's Digihaler system. The collaboration between Phil and Teva Pharmaceuticals aims to make it easier, quicker, and more affordable for patients to get and renew their Digihaler prescription. Patients may fill prescriptions, check prescription records, and get help understanding insurance benefits by using the PhilRx Patient Access Platform.
List of Smart inhalers Key companies in the market
-
AstraZeneca (UK)
-
Adherium (New Zealand)
-
Cohero Health (US)
-
Gecko Health Innovations Inc (US)
-
GlaxoSmithKline (UK)
-
Inspiro Medical (Israel)
-
Propeller Health (US)
Smart Inhalers Market Highlights:
Smart Inhalers Market Highlights:
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
